Additionally, GDL treatment increased protein levels of Nrf2 and its downstream antioxidant genes (GCLC, HO-1, and NQO1) in the hippocampal region in WD mice, suggesting that GDL exerts a neuroprotective effect in WD via the Nrf2 signaling pathway. Here, GCLC is linked to Wilson disease.